Proteomic analysis of the effect of iptakalim on human pulmonary arterial smooth muscle cell proliferation
AIM: To investigate the anti-proliferative effect of iptakalim (Ipt), a newly selective K(ATP) channel opener, in endothelin-1 (ET-1)-induced human pulmonary arterial smooth muscle cells (PASMCs) using proteomic analysis.
METHODS: Human PASMCs were incubated with ET-1 (10(-8) mol/L) and ET-1 (10(-8) mol/L) plus iptaklim (10(-5) mol/L) for 24 h. Analysis via 2-DE gel electrophoresis and MALDI-TOF-MS was employed to display the different protein profiles of whole-cell protein from cultures of control, ET-1 treatment alone, and treatment with ET-1 and iptaklim combined. Real time RT-PCR and Western blot analysis were used to confirm the proteomic analysis.
RESULTS: When iptakalim inhibited the proliferative effect of ET-1 in human PASMCs by opening the K(ATP) channels, the expression of different groups of cellular proteins was changed, including cytoskeleton-associated proteins, plasma membrane proteins and receptors, chaperone proteins, ion transport-associated proteins, and glycolytic and metabolism-associated proteins. We found that iptakalim could inhibit the proliferation of human PASMCs partly by affecting the expression of Hsp60, vimentin, nucleoporin P54 (NUP54) and Bcl-X(L) by opening the K(ATP) channel.
CONCLUSION: The data suggest that a wide range of signaling pathways may be involved in abolishing ET-1-induced proliferation of human PASMCs following iptakalim treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2009 |
---|---|
Erschienen: |
2009 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Acta pharmacologica Sinica - 30(2009), 2 vom: 19. Feb., Seite 175-83 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yang, Ming-Xia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Endothelin-1 |
---|
Anmerkungen: |
Date Completed 28.04.2009 Date Revised 20.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/aps.2008.30 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM185986145 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM185986145 | ||
003 | DE-627 | ||
005 | 20231223173440.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2009 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/aps.2008.30 |2 doi | |
028 | 5 | 2 | |a pubmed24n0620.xml |
035 | |a (DE-627)NLM185986145 | ||
035 | |a (NLM)19169269 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yang, Ming-Xia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Proteomic analysis of the effect of iptakalim on human pulmonary arterial smooth muscle cell proliferation |
264 | 1 | |c 2009 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.04.2009 | ||
500 | |a Date Revised 20.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a AIM: To investigate the anti-proliferative effect of iptakalim (Ipt), a newly selective K(ATP) channel opener, in endothelin-1 (ET-1)-induced human pulmonary arterial smooth muscle cells (PASMCs) using proteomic analysis | ||
520 | |a METHODS: Human PASMCs were incubated with ET-1 (10(-8) mol/L) and ET-1 (10(-8) mol/L) plus iptaklim (10(-5) mol/L) for 24 h. Analysis via 2-DE gel electrophoresis and MALDI-TOF-MS was employed to display the different protein profiles of whole-cell protein from cultures of control, ET-1 treatment alone, and treatment with ET-1 and iptaklim combined. Real time RT-PCR and Western blot analysis were used to confirm the proteomic analysis | ||
520 | |a RESULTS: When iptakalim inhibited the proliferative effect of ET-1 in human PASMCs by opening the K(ATP) channels, the expression of different groups of cellular proteins was changed, including cytoskeleton-associated proteins, plasma membrane proteins and receptors, chaperone proteins, ion transport-associated proteins, and glycolytic and metabolism-associated proteins. We found that iptakalim could inhibit the proliferation of human PASMCs partly by affecting the expression of Hsp60, vimentin, nucleoporin P54 (NUP54) and Bcl-X(L) by opening the K(ATP) channel | ||
520 | |a CONCLUSION: The data suggest that a wide range of signaling pathways may be involved in abolishing ET-1-induced proliferation of human PASMCs following iptakalim treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Endothelin-1 |2 NLM | |
650 | 7 | |a N-(1-methylethyl)-1,1,2-trimethylpropylamine |2 NLM | |
650 | 7 | |a Propylamines |2 NLM | |
700 | 1 | |a Liu, Zheng-Xia |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shu |e verfasserin |4 aut | |
700 | 1 | |a Jing, Yu |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shi-Jiang |e verfasserin |4 aut | |
700 | 1 | |a Xie, Wei-Ping |e verfasserin |4 aut | |
700 | 1 | |a Ma, Lei |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Chang-Liang |e verfasserin |4 aut | |
700 | 1 | |a Wang, Hong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta pharmacologica Sinica |d 2000 |g 30(2009), 2 vom: 19. Feb., Seite 175-83 |w (DE-627)NLM111735181 |x 1745-7254 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2009 |g number:2 |g day:19 |g month:02 |g pages:175-83 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/aps.2008.30 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2009 |e 2 |b 19 |c 02 |h 175-83 |